(Alliance News) - The FTSE 100 hit another record high on Wednesday, despite concerns over the US shutdown, as pharmaceutical stocks powered higher, with AstraZeneca up 11% alone. Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday as markets got over a wobble on the shutdown of the US government, while the blue-chip index was pushed higher due to a surge in pharmaceutical firms. Read More
(Alliance News) - Stock prices in London opened higher on Wednesday, and the FTSE 100 reached a new intra-day record, shaking off any jitters as the US government shut down overnight. Read More
(Alliance News) - The FTSE 100 recorded strong gains on Friday as US data pointed to resilient consumer spending and relatively subdued inflation, keeping hoped for rate cuts across the pond on track. Read More
(Alliance News) - Blue chips ended the week in subdued fashion, giving up early gains, as tepid UK economic growth data and a drop in US consumer sentiment weighed on the mood. Read More
Hikma Pharmaceuticals PLC - London-based drugmaker with operations in Jordan and US - Non-Executive Director Laura Balan buys 3,500 shares at 1,820.70 pence each, worth GBP63,726, on Friday. Read More
(Alliance News) - The FTSE 100 outperformed European peers on Monday as investors weighed geopolitical developments ahead of a busy week of economic data. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and Monday and not separately reported by Alliance News: Read More
(Alliance News) - The FTSE 100 fell in London on Thursday, while the pound climbed, after the Bank of England lowered interest rates in a tight vote which saw hopes for further cuts this year pared. Read More
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it continues to expect revenue and profit growth in 2025, despite core operating profit declining in the first half. Read More
(Alliance News) - London stocks were mixed at Thursday's market open, as investors look to a UK interest rate decision at midday and weigh an acceleration in house prices during July. Read More
(Alliance News) - Hikma Pharmaceuticals PLC has pledged to invest USD1 billion by 2030 to further expand its US manufacturing and R&D capabilities. Read More
(Alliance News) - Miners and defence stocks helped support the FTSE 100 on Thursday, shaking off a stronger pound, which serves as a headwind for the international earner-heavy index. Read More
(Alliance News) - The FTSE 100 closed higher on Thursday, despite weak UK growth figures and renewed geopolitical tensions and tariff worries. Read More
